Adherium Ltd. Announces Promising Interim Results from iCARE Study with Hailie® Smartinhaler®, Showing Record Adherence in COPD and Asthma Care
Adherium Ltd. has announced promising interim results from the iCARE study, which investigated chronic respiratory care using its Hailie® Smartinhaler® technology. The study, involving 4,000 devices and 2,500 COPD and asthma patients, showed significant adherence improvements and potential cost savings. Nearly 850 participants demonstrated high engagement levels. Detailed results are expected later this year, emphasizing the technology's potential to enhance patient outcomes and establish a scalable, value-based care model.
Adherium Ltd. has announced preliminary results from the iCARE study, a significant real-world investigation into chronic respiratory care using its Hailie® Smartinhaler® technology. Conducted in collaboration with Intermountain Health and CareCentra, the study involved 4,000 devices supporting up to 2,500 COPD and asthma patients across five facilities over two years. Preliminary findings indicate substantial adherence improvements and potential cost savings, with nearly 850 participants demonstrating high engagement levels. Detailed results, including breakdowns by disease category and patient severity, are anticipated later this year. The study highlights the potential of Adherium’s technology to enhance patient outcomes and establish a scalable, value-based care model. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adherium Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN74652) on September 16, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
